## Abstract Acute and chronic graftβversusβhost disease (GVHD) are major complications after allogeneic hematopoietic stem cell transplantation. Systemic corticosteroid is the first line of therapy but only half of the patients will respond. The management of steroidβrefractory or steroidβdependent
Extracorporeal Photopheresis in the Treatment of Graft-vs-Host Disease
β Scribed by FrancineM. Foss
- Publisher
- Springer-Verlag
- Year
- 2003
- Tongue
- English
- Weight
- 84 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1203-4754
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory therapy developed for cutaneous T-cell lymphoma, has shown promise in treating chronic graft-versus-host disease (cGvHD) in uncontrolled studies. The purpose of this study was to further examine the effects of ECP on cGvHD. E
Photopheresis is a pheresis-based therapy that is currently available at approximately 70 medical centers worldwide. Recent evidence indicates that extracorporeal photopheresis can significantly prolong life, as well as induce a 6&750/0 response rate among individuals with advanced cutaneous T-cell
The Department for Bone Marrow Transplantation and Hematology/Oncology was founded in 1994. Performing 90 transplantations per year it is one of the largest transplant centers in Germany, focusing on unrelated stem cell transplantations. Our extensive basic and clinical research programme is also co
## Background: Extracorporeal photopheresis (ecp) is effective in immune-mediated disorders. a prospective, uncontrolled pilot study was conducted to evaluate the safety and efficacy of ecp in patients with active crohn's disease (cd) who were refractory to or intolerant of immunosuppressants and/o